FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention describes compounds applicable for treating or relieving a neurodegenerative disorder. There are also described methods of treating or relieving said disorders with said method involving the introduction a compound according to the present invention or a composition containing said compound in a patient.
EFFECT: method may be applicable for treating or relieving eg Alzheimer's disease.
21 cl, 9 ex, 22 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS, USEFUL FOR TREATMENT OF NEURODEGENERATIVE MALFUNCTIONS | 2006 |
|
RU2440367C2 |
| ISOINDOLINE COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASE | 2015 |
|
RU2692258C2 |
| AMYLOID-BINDING AGENTS | 2010 |
|
RU2517174C2 |
| INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION | 2008 |
|
RU2515318C2 |
| NEW COMPOUNDS FOR TREATING DISEASES, ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS | 2011 |
|
RU2603008C2 |
| METHOD OF SYNTHESISING E1-ACTIVATING ENZYME INHIBITORS | 2008 |
|
RU2553476C2 |
| SYNTHESIS OF RESORCYLIC ACID LACTONES USED AS THERAPEUTIC AGENTS | 2009 |
|
RU2534527C2 |
| INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION | 2008 |
|
RU2523790C2 |
| SUBSTITUTED N-ARYLBENZAMIDES AND RELATED COMPOUNDS FOR TREATING AMYLOID DISEASES AND SYNUCLEINOPATHY | 2005 |
|
RU2381213C2 |
| COMPOSITIONS FOR TREATMENT OF NEURODEGERATIVE DISEASES | 2018 |
|
RU2792562C2 |
